NNVC - NanoViricides, Inc. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : NNVC - NanoViricides, Inc.

NNVC 1.120

-7.4%

Jan 9 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Another_Voice_2 who wrote (10079)	4/17/2018 8:52:30 PM
From: BoredMember	Read Replies (2) of 12873

He fully funded the purchase of the facility with his own money and then sold it back at cost. He and his wife have dedicated years to this venture, and remember, she gave up a very successful career with GE, McKinsey and other blue chip firms. He has granted Nanoviricides all rights to market and sell the finished treatments for a mere 30 percent on his expenses to bring the product to fruition and market. He tirelessly is in the lab training and supervising the many, many Theracour employees that are diligently working on getting the nanoviricides optimized. He is a passionate and articulate spokesperson and champion for the company at public and private events. Need I say more?

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next